[Components] In 1 vial ■ Active ingredient: Recombinant human growth hormone -------------------- 16 IU (5.3 mg) ■ Solvent: Water for injection (KP) ---------------------------------------------------- 1 mL
[Dosage and administration] Adult GH deficiency: A starting dose of 0.125 IU (0.04 mg)/kg of body weight (given in divided doses 6 to 7 times per week) is administered subcutaneously. The dose may be increased gradually to a maximum of 0.25 IU (0.08 mg)/kg of body weight per a week. Dose increase is adjusted based on the adverse event and serum IGF-1 concentrations according to age and gender. The minimum effective dose should be used. In case of continuous edema or severe dysaesthesia, the dose should be decreased to avoid carpal tunnel syndrome.